The modifications of the SOD mimics led to an improvement of the anti-inflammatory and antioxidant activities in a cellular model, consisting of epithelial intestinal cells HT29-MD2 under LPS-mediated inflammation and relevant to IBD. The gene discussed is SOD1; the disease is inflammatory bowel disease.